Body mass index (BMI) values that are above average and the development of overweight from childhood to adulthood are risk factors for gestational hypertension and pre-eclampsia, but normalizing BMI from childhood to conception reduces such risks, according to a study.
Accelerometer-assessed moderate-to-vigorous physical activity (MVPA) at baseline shows an inverse relationship with incident diabetes among individuals aged ≥50 years, a recent study involving a US Hispanic/Latino population has found.
Following treatment with nivolumab, a programmed death (PD)-1 inhibitor, the expression of inflammatory markers seems to correlate with better survival and treatment response in hepatocellular carcinoma (HCC) patients, a recent study has shown. This suggests that antitumour inflammatory mechanisms play a role in the action of nivolumab.
Patients with acute ischaemic stroke undergoing endovascular treatment are at heightened risk of poor functional outcome and symptomatic intracranial haemorrhage (sICH) in the presence of hyperglycaemia at admission, a study has found.
The combination of proton beam therapy with the intravitreal administration of anti-vascular endothelial growth factor (VEGF) reduces the need for anti-VEGF reinjection in the eyes of patients with exudative age-related macular degeneration (eAMD), a recent study has shown.
Individuals with atrial fibrillation (AF), diabetes, or low albumin levels are at increased risk of mortality following transcatheter aortic valve replacement (TAVR), with AF patients who are not anticoagulated being at greatest risk of dying, reveals a study.
Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.